Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01190384 · ClinicalTrials.gov registry record · NA

The Effect of Whole Beans on Inflammation and Satiety

A NA study of Metabolic Syndrome, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT01190384 is a NA study of Metabolic Syndrome that has completed, run by University of California, Davis. The registered enrollment target is 12 participants, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01190384, a NA study of Metabolic Syndrome, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

Determine whether eating beans with a high fat meal will reduce the inflammatory response in people with the metabolic syndrome and increase feelings of satiety.

Conditions Studied

Interventions

  • OTHER Couscous plus fiber
  • DIETARY_SUPPLEMENT Grape seed extract
  • OTHER Bean Soup

Study Locations (1)

California

  • Ragle Human Nutrition Research Center - Davis

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2010-08
Est. Completion 2014-04
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT01190384

The ClinicalTrials.gov registry entry for NCT01190384 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (99% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Metabolic Syndrome appearing as the primary indexed condition, and to 3 interventions - of which Couscous plus fiber is the first listed.

NCT01190384 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01190384 about?

NCT01190384 is a clinical study titled "The Effect of Whole Beans on Inflammation and Satiety". Determine whether eating beans with a high fat meal will reduce the inflammatory response in people with the metabolic syndrome and increase feelings of satiety.

What is the current status of trial NCT01190384?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2010-08. Estimated completion is 2014-04.

What conditions does trial NCT01190384 study?

This clinical trial studies the following conditions: Metabolic Syndrome.

What interventions are being tested in trial NCT01190384?

The interventions under investigation include: Couscous plus fiber (OTHER), Grape seed extract (DIETARY_SUPPLEMENT), Bean Soup (OTHER).

Who is sponsoring clinical trial NCT01190384?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01190384 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.